Given how prominent these merger and acquisition deals are in the medical device manufacturing community, this page is a dedicated resource to offer a quick glance at all the transactions made in 2025. Return often to stay updated on the latest deals occurring within the industry and get a brief recap of the most important details.

Consolidation between suppliers or medical device OEMs has become common for companies to remain relevant in the medical device industry. The industry’s environment is in a constant state of flux, as peer organizations absorb specialized firms. The factors driving this trend are myriad, and the outcomes enable access to new technologies, customers, regions, and/or capabilities.

GE HealthCare—Intelerad

Intelerad is a medical imaging software and digital enterprise workflow solutions provider with a strong presence in outpatient ambulatory care settings. Its cloud-first products are designed for radiology and cardiology for both the inpatient and outpatient settings.
Date of Announcement: November 20, 2025
Value: $2.3 billion
More info

Solventum—Acera Surgical

Acera was founded in 2013 and has developed and sold synthetic treatment options for soft tissue repair using its electrospinning technology platform.
Date of Announcement: November 20, 2025
Value: Up to $850 million
More info

Abbott—Exact Sciences

Exact Sciences specializes in early detection of cancer and support of personalized treatments. Its product offerings support patients and healthcare providers before, during, and after a cancer diagnosis.
Date of Announcement: November 20, 2025
Value: $21 billion (equity) $23 billion (enterprise)
More info

Vance Street Capital—Injectech

Injectech specializes in injection molding and cleanroom assembly and is an engineering partner to medical device OEMs. The company develops polymer-based fluid management components, including male and female luers, tube-to-tube connectors, check valves, spikes, and custom assemblies.
Date of Announcement: November 19, 2025
Value: Not disclosed
More info

Nanox—VasoHealthcare IT

VHC IT is a healthcare information technology provider that serves U.S. hospitals and healthcare facilities. The company boasts a team of professional specializing in healthcare IT implementation.
Date of Announcement: November 19, 2025
Value: $800,000
More info

H&T Presspart—Plas-Tech Engineering

H&T Presspart acquired a majority stake in Plas-Tech. The company focuses on design, development, and manufacturing of parenteral syringe systems and medical devices for the pharma and biotech industries, leveraging advanced molding technologies and design for manufacturing expertise.
Date of Announcement: November 10, 2025
Value: Not disclosed
More info

Laborie Medical—Organon

Organon is divesting its JADA system to Laborie. JADA is a medical device that uses a low-level intrauterine vacuum to control and treat abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.
Date of Announcement: November 7, 2025
Value: Up to $465 million
More info

JLL Partners—Parks Medical Electronics

Parks Medical Electronics is a manufacturer of medical Doppler ultrasound systems for the hospital, clinic, and veterinary settings, and the Flo-Lab Vascular system, a diagnostic tool to evaluate blood glow in patients with peripheral arterial disease.
Date of Announcement: November 5, 2025
Value: Not disclosed
More info

Blackstone & TPG—Hologic

Hologic will be acquired by funds managed by Blackstone and TPG, privatizing the company. The company will be delisted from Nasdaq, and will keep its Marlborough, Mass. headquarters and brand.
Date of Announcement: October 21, 2025
Value: $79/share, enterprise value up to $18.3 billion
More info

Allegheny—Holbrook Tool and Molding

This strategic acquisition strengthens Allegheny’s capabilities in precision tooling and complex component manufacturing, while expanding its footprint in the North American market. It also aligns with Allegheny’s long-term strategy to invest in technology, talent, and facilities that enhance its ability to deliver innovative solutions using high-performance polymers for the medical and aerospace industries.
Date of Announcement: October 17, 2025
Value: Not disclosed
More info

Excelitas—Luxium Solutions

This acquisition represents the seventh completed transaction by Excelitas since 2017, building on the momentum of the Noblelight acquisition in January 2024. This marks a bold step forward for the company, unlocking new possibilities and expanding technological horizons.
Date of Announcement: October 14, 2025
Value: Not disclosed
More info

Vance Street Capital—MRPC

MRPC provides end-to-end product lifecycle support, from design and development through manufacturing and finished device assembly, backed by vertically integrated capabilities in silicone molding, thermoplastic molding, multi-material molding, cleanroom assembly, packaging, sterilization management, and supply chain services.
Date of Announcement: October 14, 2025
Value: Not disclosed
More info

Natus Medical—Holberg EEG

Holberg EEG is the developer of the world’s first artificial intelligence model capable of automatic and comprehensive clinical EEG interpretation with accuracy that matches leading medical experts.
Date of Announcement: September 30, 2025
Value: Not disclosed
More info

Resonetics—Eden Holdings

The deal adds micro molding, insert molding, and advanced machining and tooling to complement Resonetics’ metal processing capabilities. It also expands the company’s Swiss machining and EDM machining offerings.
Date of Announcement: September 29, 2025
Value: Not disclosed
More info

Glooko—Monarch Medical Technologies

Monarch Medical is the developer of the EndoTool glucose management system. EndoTool is a software platform for inpatient insulin dosing and glycemic management.
Date of Announcement: September 23, 2025
Value: Not disclosed
More info

VANGEST—Micro Systems & Optimold

Both companies boast over two decades in high-precision mold making and injection molding for the healthcare and medtech sectors. The acquired businesses have manufacturing facilities in both the UK and Singapore.
Date of Announcement: September 18, 2025
Value: Not disclosed
More info

TEAM Technologies—TAG3 Engineering

TAG3 is a full-service medtech design, development, and manufacturing company. The company contributes U.S.-based front end innovation capabilities to TEAM Tech’s specialty manufacturing solutions for the medical device industry.
Date of Announcement: September 17, 2025
Value: Not disclosed
More info

Avanos Medical—Nexus Medical

Nexus is the manufacturer of the proprietary TKO anti-reflux needleless connector technology. TKO is designed to support safer, more consistent nutrition and medication delivery in high-acuity settings like neonatal and pediatric intensive care units (NICUs and PICUs).
Date of Announcement: September 15, 2025
Value: Not disclosed
More info

B. Braun—True Digital Surgery

True Digital Surgery is a Goleta, Calif.-based company that specializes in in digital robotic-assisted 3D surgical microscopy. The acquisition reinforces B. Braun’s strategy to invest in the future of digital microsurgery and expands its share in this growing segment.
Date of Announcement: September 12, 2025
Value: Not disclosed
More info

GE HealthCare—icometrix

icometrix provides AI-powered brain imaging analysis for neurological disorders like Alzheimer’s disease. icometrix will complement GE HealthCare’s MR-guided AI-assisted scanning expertise with analysis and reporting in neurological disease assessment.
Date of Announcement: September 10, 2025
Value: Not disclosed
More info

Boston Scientific—Elutia

Elutia will sell its EluPro and CanGaroo bioenvelopes to Boston Scientific. The bioenvelopes were designed to protect patients receiving implantable medical devices.
Date of Announcement: September 9, 2025
Value: $88 million
More info

Innova Engineered Plastics—PolyCraft Tech

Innova Engineered Plastics’ purchase of PolyCraft Tech, a San Diego-based specialty manufacturer of precision cast urethane enclosures and components, expands Innova’s design and manufacturing capabilities and strengthens its presence on the West Coast.
Date of Announcement: Sept. 2, 2025
Value: Not Disclosed
More info

Quasar Medical—Nordson Medical’s Ireland, Mexico Facilities

Quasar Medical completed its acquisition of Nordson Corporation’s design and development contract manufacturing businesses in Galway, Ireland; and Tecate, Mexico. The deal fosters Quasar’s evolution into a fully integrated contract development and manufacturing organization, offering customers worldwide concept-to-commercialization solutions.
Date of Announcement: Sept. 2, 2025
Value: Not Disclosed
More Info

Medical Manufacturing Technologies (MMT)—Innova Design

Innova Design is a pioneer in the bonding industry, credited with developing the first commercial catheter laser bonder in 2002. The company now boasts is sixth generation of American-made laser bonders. Innova has produced millions of balloon catheters used in interventional medical procedures around the world.
Date of Announcement: August 25, 2025
Value: Not disclosed
More info

Terumo—OrganOx

OrganOx developed the world’s first fully automated device for liver preservation, metra. Metra lets donor livers be maintained in a functioning state outside the human body for up to 24 hours.
Date of Announcement: August 24, 2025 (closed October 31)
Value: 1.5 billion
More info

Alcon—STAAR Surgical

STAAR Surgical is the manufacturer of the Implantable Collamer Lens (ICL). The acquisition includes the EVO family of lenses (EVO ICL) for vision correction for patients with moderate to high myopia, with or without astigmatism.
Date of Announcement: August 5, 2025
Value: $28 per share—$1.5 billion equity value
More info

PrecisionX Group—Hudson Technologies

Hudson Technologies is a manufacturer of mission-critical, deep drawn metal components. The deal strengthens PrecisionX’s standing as a U.S.-based provider of metal components in the aerospace & defense, medical device, satellite & space, and high-end telecommunications industries.
Date of Announcement: July 29, 2025
Value: Not disclosed
More info

Arterex—Xponent Global Inc.

With eight extrusion lines across 55,000 square feet of manufacturing space including 5,000 square feet of Class 8 cleanroom space, Xponent Global provides high-quality precise filaments, over the wire extrusion, multi-lumen, taper tubing, para tubing, and tight tolerance single lumen tubing for a wide range of applications from simple packaging tubes to demanding products used in neurological and laparoscopic devices.  
Date of Announcement: July 28, 2025
Value: Not disclosed
More info

UFP Technologies—Universal Plastics & Engineering Company (UNIPEC) & Techno Plastics Industries (TPI)

UNIPEC develops and manufactures precision thermoformed and heat-sealed polymer components used mainly for shielding batteries in Class III implantable medical devices. TPI is a specialty manufacturer of precision thermoplastic injection-molded components.
Date of Announcement: July 17, 2025
Value: Not disclosed
More info

Waters—Becton, Dickinson and Company (BD)

Waters is acquiring BD’s Biosciences & Diagnostic Solutions business, hoping to create an innovative life science and diagnostics leader. The combined company will have liquid chromatography, mass spectrometry, flow cytometry, and diagnostic solutions.
Date of Announcement: July 14, 2025
Value: $17.5 billion
More info

The Partner Companies—Precision Eforming

Based in Cortland, N.Y, Precision Eforming specializes in sieve and mesh products used in a variety of applications. The metal components are used in applications that separate and filter light, sound, air, or powdered materials.
Date of Announcement: July 8, 2025
Value: Not disclosed
More info

Innovia Medical—Grace Medical & Hurricane Medical

Memphis, Tenn.-based Grace Medical is a maker of single-use surgical implants, instruments, and consumables for ENT (ear, nose, and throat) procedures. Bradenton, Fla.-based Hurricane Medical manufactures single-use ophthalmic surgical products and instruments used in a wide variety of surgeries.
Date of Announcement: July 7, 2025
Value: Not disclosed
More info

Alcon—LumiThera

LumiThera is a developer of light-based innovations for ophthalmology with a photobiomodulation device to treat early and intermediate dry age-related macular degeneration. This transaction doesn’t include LumiThera’s AdaptDx and Nova/Diopsys diagnostic devices. These will be separated and spun off to LumiThera shareholders.
Date of Announcement: July 7, 2025
Value: Not disclosed
More info

TEAM Technologies—Duke Empirical Inc.

The deal broadens TEAM’s prowess in the minimally invasive, cardiology, and interventional markets, providing customers with a fully integrated, turnkey solution that combines Duke’s specialized front-end design and catheter expertise with TEAM’s comprehensive capability set and global manufacturing footprint. Duke designs, develops, and manufactures medical devices focused on advanced catheters and minimally invasive delivery systems.
Date of Announcement: July 7, 2025
Value: Not disclosed
More info

EnChannel—Acutus Medical

EnChannel will acquire the AcQMap high-resolution imaging and mapping platform assets from Acutus Medical. The deal includes substantive intellectual property, quality and regulatory documentation, clinical data, a limited number of AcQMap systems, and associated catheter devices for research and development purposes.
Date of Announcement: July 1, 2025
Value: Not disclosed
More info

Verge Medical—2MG Medical

Verge Medical acquired the RoVo system and its Temporary Occlusion Embolectomy (TOE) tech from 2MG Medical. The RoVo system addresses the risk of distal embolization with this novel TOE technique.
Date of Announcement: June 30, 2025
Value: Not disclosed
More info

Medical Manufacturing Technologies (MMT)—Comco

Comco is the creator of the award-winning MicroBlaster, a technique used for deburring, texturing, cleaning, and modifying part surfaces. MMT said the move will significantly bolster its abrasive technology offerings and vastly expand its microblasting capabilities.
Date of Announcement: June 24, 2025
Value: Not disclosed
More info

EssilorLuxottica—Optegra Clinics

EssilorLuxottica is purchasing Optegra, a highly integrated ophthalmology platform operating in five key European markets: the United Kingdom, Czech Republic, Poland, Slovakia, and the Netherlands. The acquisition represents a significant milestone in EssilorLuxottica’s medtech strategy, building on an offering that currently expands beyond frames and lenses to include artificial intelligence (AI)-powered technologies, wearables, medical instruments, and science-backed eye care solutions.
Date of Announcement: May 30, 2025
Value: Not disclosed
More info

Quasar Medical—Nordson Medical

Quasar Medical, a manufacturer of interventional and complex minimally invasive devices, began an agreement to acquire Nordson’s design and development contract manufacturing businesses in Galway, Ireland and Tecate, Mexico.
Date of Announcement: May 29, 2025
Value: Not disclosed
More info

Merit Medical—Biolife Delaware

Biolife is based in Sarasota, Fla. and manufactures patented hemostatic devices under the names StatSeal and WoundSeal. The deal was made so Merit can offer more products to standardize, simplify, and minimize post-procedure care and maintenance.
Date of Announcement: May 20, 2025
Value: $120 million
More info

Resonetics—Medical Component Specialists

Resonetics acquired the nitinol gun drilling operations and assets of Medical Component Specialists’ (MCS) new Boston, N.H. facility. The acquisition is another key investment in Resonetics’ U.S.-based nitinol strategy.
Date of Announcement: May 19, 2025
Value: Not disclosed
More info

Safe Life—AEDMAX.PL

AEDMAX.PL is a Poland-based company specializing in automated external defibrillators (AEDs), first aid equipment, and first aid training. the company is Safe Life’s first acquisition in Poland.
Date of Announcement: May 7, 2025
Value: Not disclosed
More info

Safe Life—resQshock

resQshock is a Swiss company that offers sales and service of automated external defibrillators (AEDs). The acquisition is part of Safe Life’s European growth strategy to address the growing demand for AEDs and public safety equipment.
Date of Announcement: May 6, 2025
Value: Not disclosed
More info

Firefly Neuroscience—Evoke Neuroscience

Evoke is a company specializing in technologies to aid in brain health assessment. Thanks to the deal, Firefly now touts a proprietary database of over 180,000 standardized EEG/ERP assessment records.
Date of Announcement: May 5, 2025
Value: $6 million
More info

Streamex—BioSig

BioSig entered into a Letter of Intent to enter a proposed merger with Streamex Exchange Corp., a real-world asset tokenization firm, in an all-stock transaction.
Date of Announcement: May 5, 2025
Value: Not disclosed; all-stock transaction
More info

Resmed—VirtuOx

VirtuOx is an independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The company’s virtual testing platform can reduce barriers to diagnosis with fast, flexible, and affordable options.
Date of Announcement: May 1, 2025
Value: Not disclosed
More info

Ypsomed—TecMed

Ypsomed is selling Ypsomed Diabetes Care AG, including subsidiaries, patch pump development activities, and related rights to TecMed, a Swiss company controlled by Willy Michel.
Date of Announcement: April 22, 2025
Value: CHF 420 million (~$517 million)
More info

RadNet—iCAD

iCAD is a company focused on AI-powered breast health solutions. The combination is expected to accelerate RadNet’s global leadership and commitment to AI-powered breast cancer screening.
Date of Announcement: April 15, 2025
Value: $3.61 per share (~$130 million)
More info

Innovize & Excel Scientific—Zenith Adhesive Components (ZAP)

ZAP is an Irish contract manufacturer to wound care and medical device makers, producing a wide variety of die-cut and slit adhesive components for medical use.
Date of Announcement: April 3, 2025
Value: Not disclosed
More info

Alcon—Lensar

Lensar is a maker of advanced systems for cataract treatment and management of astigmatism. The acquisition includes Lensar’s Ally robotic cataract laser treatment system, Streamline software technology, and Lensar legacy laser system.
Date of Announcement: March 24, 2025
Value: Up to $16.75 per share (~$430 million)
More info

Caldera Medical—Johnson & Johnson MedTech

Caldera Medical, a women’s health device company, acquired J&J MedTech’s Gynecare TVT family of products, a suite of minimally invasive treatment options for women with stress urinary incontinence
Date of Announcement: March 20, 2025
Value: Not disclosed
More info

Arthur G. Russell Co. Inc.—ProMATIC Automation

ProMATIC is a provider of customized automation systems. AGR selected the company due to its ability to deliver flexible, customer-focused automation solutions.
Date of Announcement: March 17, 2025
Value: Not disclosed
More info

Rimkus Consulting Group—Human Factors Consulting Services Incorporated (HFCSI)

HFCSI offers user-centered design, usability testing, and risk assessments. Their medical device consulting expertise will offer Rimkus new opportunities to expand its capabilities in the medical and healthcare industries.
Date of Announcement: March 6, 2025
Value: Not disclosed
More info

Boston Scientific—SoniVie

The ultrasound-based renal denervation therapy technology will expand the company’s Interventional Cardiology Therapies offerings.
Date of Announcement: March 3, 2025
Value: $360 million; additional $180 million upon achievement of regulatory milestone.
More info

Teleflex—Biotronik

The acquisition of Biotronik’s Vascular Intervention business will expand the Teleflex Interventional portfolio to include drug-coated balloons, drug-eluting stents, covered stents, balloon and self-expanding bare metal stents, and balloon catheters.
Date of Announcement: Feb. 27, 2025
Value: €760 million
More info

Thermo Fisher Scientific—Solventum

Solventum began a deal to sell its Purification & Filtration business to Thermo Fisher. The business is a leading provider of purification and filtration tech used in biologics production, medical technologies, and industrial applications.
Date of Announcement: Feb. 25, 2025
Value: $4.1 billion
More info

Quest Diagnostics—Fresenius Medical Care

FMC began an agreement to divest certain assets of its wholly-owned Spectra Laboratories business to Quest Diagnostics. Spectra Labs provides renal-specific lab testing services in the U.S.
Date of Announcement: Feb. 24, 2025
Value: Not disclosed
More info

NanoVibronix—ENvue

ENvue is a privately-held provider of enteral feeding solutions. NanoVibronix believes the transaction will bolster the combined company’s market position in enteral feeding tech and therapeutic medical devices.
Date of Announcement: Feb. 14, 2025
Value: Not disclosed; stock-for-stock transaction
More info

Medical Manufacturing Technologies—GenX Medical

Medical Manufacturing Technologies (MMT) is bolstering its extrusion prowess with the purchase of medtech tubing and custom extrusion supplier GenX Medical.
Date of Announcement: Feb. 4, 2025
Value: Not disclosed
More info

Jabil—Pharmaceutics International Inc.

Jabil Inc. has completed a deal for contract development and manufacturing organization (CDMO) Pharmaceutics International Inc. (Pii), which specializes in early-stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing.
Date of Announcement: Feb. 4, 2025
Value: Not disclosed
More info

Integer—Precision Coating

Integer Holdings Corporation has acquired substantially all the assets of Precision Coating. The deal was made on January 7, 2025, and increased Integer’s service offerings to include differentiated and proprietary coatings. 
Date of Announcement: Feb. 4, 2025
Value: $152 million
More info

Arterex—Adroit USA Inc.

Arterex acquired Adroit USA, which expands its capabilities to provide customers the benefits of a cost-effective, high-tech alternative production source to China while leveraging Adroit USA Inc.’s existing capabilities and workforce to quickly and fully scale production. 
Date of Announcement: Feb. 3, 2025
Value: Not disclosed
More info

Philips Emergency Care Biz—Bridgefield Capital

Philips has agreed to sell its Emergency Care business to Bridgefield Capital, a U.S.-based investment firm. The company and the Emergency Care business will enter an exclusive brand license agreement to use the Philips brand for manufacturing, sales, and marketing of Emergency Care products worldwide for up to 15 years.
Date of Announcement: Jan. 28, 2025
Value: Not disclosed
More info

Cormica—Focus Laboratories

Cormica, a leading global medical device and pharmaceutical testing group, has announced the acquisition of Focus Laboratories. This expands Cormica’s US presence with Focus Laboratories’ Allentown, Pennsylvania, and Palm Harbor, Florida, facilities.
Date of Announcement: Jan. 28, 2025
Value: Not disclosed
More info

Akkodis—Raland Compliance Partners

Akkodis, a global digital engineering company, acquired Raland Compliance Partners, a specialist provider of quality and regulatory compliance services to the Life Sciences industry. This expands Akkodis’ Life Sciences industry capabilities.
Date of Announcement: Jan. 27, 2025
Value: Not disclosed
More info

Gainline Capital Partners—M&M International

M&M manufactures precision-engineered stainless-steel tubing primarily for the medical device end market. The deal occurs at a particularly active time for Gainline as it deploys its second fund. Last week the firm announced a majority investment in IMS Technologies, a leading audiovisual and systems integration company based in Pennsylvania.
Date of Announcement: Jan. 21, 2025
Value: Not disclosed
More info

Aptyx—Medical Murray’s NC Facility

Aptyx has acquired Medical Murray’s Charlotte, North Carolina, facility, which develops and produces catheter-based interventional products and transcatheter implants. This will help Aptyx launch its Interventional Systems.
Date of Announcement: January 21, 2025
Value: Not disclosed
More info

Arterex—Phoenix S.r.l.

Arterex has acquired an Italian-based medical manufacturer, Phoenix S.r.l., expanding its capabilities in medical device development, finished device assembly, and packaging to Europe.
Date of Announcement: January 21, 2025
Value: Not disclosed
More info

NAMSA—WuXi AppTec Medical Device Testing Operations

NAMSA has entered an agreement to acquire the U.S.-based medical testing operations of WuXi AppTec, which will enhance stockholder value. NAMSA will oversee WuXi’s Minnesota and Georgia facilities.
Date of Announcement: January 17, 2025
Value: Not disclosed
More info

KARL STORZ—T1V’s Medical Biz

Acquiring T1V’s medical business marks a major step in shaping integrated hardware and software solutions for digital surgery in global operating rooms, complementing KARL STORZ’s endoscopes and medical solutions. T1V’s CollaboratOR has been sold exclusively through KARL STORZ since 2018.
Date of Announcement: January 8, 2025
Value: Not disclosed
More info

Boston Scientific—Bolt Medical

Bolt Medical is a developer of an intravascular lithotripsy (IVL) laser-based platform to treat coronary and peripheral artery disease. Boston Scientific initially developed the Bolt IVL concept, which helped to establish Bolt Medical in 2019.
Date of Announcement: January 8, 2025
Value: $664 million—$443 million upfront, up to $221 million upon achievement of regulatory milestones
More info

Myant Corp.—mmHg Inc.

mmHg Inc. is a digital health company specializing in remote blood pressure monitoring, cardiovascular risk reduction, and chronic disease management. The deal is part of a broader strategy of “prevention through precision” to drive forward a new era of personalized, artificial intelligence (AI)-enabled remote healthcare.
Date of Announcement: January 7, 2025
Value: Not disclosed
More info

GEON Performance Solutions—Foster Corporation

Foster Corporation is a differentiated compounder of biomedical polymers used in the high-growth healthcare and medical device industry. This furthers GEON’s strategy to enhance and diversify its portfolio.
Date of Announcement: January 7, 2025
Value: Not disclosed
More info

Phillips Medisize—Vectura

Phillips Medisize (a Molex company) acquired Vectura’s proprietary technology and combination product development expertise in dry powder inhalers (DPI).
Date of Announcement: January 7, 2025
Value: Not disclosed
More info

Stryker—Inari Medical

Inari offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs. Inari complements Stryker’s neurovascular business, which already includes mechanical thrombectomy solutions for peripheral vascular diseases.
Date of Announcement: January 6, 2025 (closed Fe. 19, 2025)
Value: $80 per share (about $4.9 billion)
More info

Hologic—Gynesonics

Gynesonics’ Sonata system is meant for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, included those related to heavy menstrual bleeding.
Date of Announcement: January 6, 2025
Value: $350 million
More info

Intek Plastics—Five Star Plastics

Five Star Plastics has been acquired by Intek Plastics and will operate as a separate division under Intek. Together, the companies will offer a more comprehensive suite of services, providing greater value to customers across diverse industries. 
Date of Announcement: January 6, 2025
Value: Not disclosed
More info

Check out 2024’s M&A round up.